Cloned transmembrane receptor for 24-hydroxylated vitamin d compounds and uses thereof
AssigneeShriners Hospital For Children
InventorRene St-Arnaud
Life of this patent
Estimating the term…
Abstract
The instant invention relates to the use of 24-hydroxylated vitamin D compounds as therapeutics in mammalian bone fracture repair. In addition, the instant invention relates to novel 24-hydroxylated vitamin D compound receptors which can be employed in the development of compounds capable of facilitating fracture repair in animals. The instant invention also relates to nucleic acids encoding such receptors as well as vectors, host cells, transgenic animals comprising such nucleic acids and screening assays employing such receptors.
Claims8
A method of identifying a compound capable of binding to a 24-hydroxylated vitamin D compound receptor, the method comprising:
- (a) contacting a 24-hydroxylated vitamin D compound receptor with a candidate compound;
- and (b) determining whether the candidate compound binds to the 24-hydroxylated vitamin D compound receptor.
Dependencies are inferred from the claim text.